Skip to content
The Longevity Archive

Legal status · United Kingdom

Is Thymosin Alpha-1 legal in the United Kingdom?

Not approvedImmuneEvidence: Moderate

No. Thymosin Alpha-1 is not an approved medicine in the United Kingdom; its classification is "Not licensed". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.

Thymosin Alpha-1 in the United Kingdom at a glance

ClassificationNot licensed
MHRA approval statusNot approved by MHRA
Evidence levelModerate (research strength: Strong)
ReviewedSep 2026

Classification and note come from the Thymosin Alpha-1 profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.

What this means

  • 01

    No product containing Thymosin Alpha-1 is approved by MHRA for any use in the United Kingdom, so nothing on the market is authorized for people.

  • 02

    "Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.

  • 03

    Importing, supplying or promoting it for human use can fall under medicines legislation in the United Kingdom. This page is general information, not legal advice.

What Thymosin Alpha-1 is

An immune-modulating thymic peptide approved in many countries for hepatitis and used as an immune adjuvant.

Thymosin Alpha-1 is a peptide originally isolated from the thymus that modulates T-cell function and innate immunity, acting through Toll-like receptor signaling in myeloid and plasmacytoid dendritic cells. Marketed as Zadaxin, it is approved in more than 30 countries for chronic hepatitis B and C and as an immune adjuvant, though it holds only orphan-drug status in the US.

Mechanism: Enhances T-cell maturation and function, modulates dendritic cells and cytokine signaling, and supports both adaptive and innate immune responses.

Regulatory history: Not FDA-approved (orphan status); approved in 30+ countries as Zadaxin

How MHRA treats this kind of product

Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.

The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Thymosin Alpha-1 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Thymosin Alpha-1 in other countries

Frequently asked questions

Is Thymosin Alpha-1 legal in the United Kingdom?

No. Thymosin Alpha-1 is not an approved medicine in the United Kingdom; its classification is "Not licensed". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Moderate.

Can I buy Thymosin Alpha-1 in the United Kingdom?

No approved product exists to buy. In the United Kingdom Thymosin Alpha-1 is classified as "Not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Thymosin Alpha-1 MHRA approved?

No. In the United Kingdom Thymosin Alpha-1 is classified as "Not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: Not FDA-approved (orphan status); approved in 30+ countries as Zadaxin. Evidence level: Moderate.

Related compounds in the United Kingdom

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Thymosin Alpha-1 live on its compound profile.

Thymosin Alpha-1 profile

This page is general information about the regulatory status of Thymosin Alpha-1 in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.